E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


Adverse events with COVID-19 vaccination among adolescents (15–18 years age group) in South India

Anju Damu Ade, Visweswara Rao Guthi, Chandrasekhar Vallepalli, Prathyusha T V D, Nagaraj Kondagunta.

Abstract
Background: Adolescent population in India is 253 million, which is the highest in the world, and every fifth person is between 10 and 19 years. COVID-19 vaccination of adolescents in the age group of 15–18 years was started from January 3rd, 2022.

Aims and Objectives: To identify the adverse events with COVID-19 vaccination (1st dose) among Adolescents (15–18 age group) and to determine the association between adverse reactions and sociodemographic factors, morbidity profile, and previous history of COVID-19.

Materials and Methods: This cross-sectional study was undertaken at COVID-19 vaccination center of SVIMS, Tirupati. AP from January 2022 to June 2022 among adolescents who visited for COVID-19 vaccination (Covaxin). Sociodemographic information was collected by interviewing them. All the adolescents who received the COVID-19 vaccine were observed for 30 min in the observation room. After 48 h, study participants were contacted through telephone to find out if any vaccine-related adverse effects developed.

Results: A total of 142 adolescents received the COVID-19 vaccine. Majority of the respondents were in the 17–18 years age group 82 (57.7%). Males (n = 102.71.8%) were higher than females (n = 40.28.2%). Out of 142, 39 (27.4%) adolescents reported adverse effects. 2(1.4%) reported adverse events within 30 min of receiving the COVID-19 vaccine, while 37 (26.1%) reported adverse events within the next 48 h after receiving the COVID-19 vaccine. Various adverse events reported were fever, dizziness/giddiness, body pains, headache, pain at the injection site, Redness at the injection site, etc.

Conclusions: Only 2 (1.4%) reported adverse events within 30 min of receiving the COVID-19 vaccine, while 37 (26.1%) reported adverse events within the next 48 h after receiving the COVID-19 vaccine. Adverse effects were mild and resolved with treatment. No serious adverse effects developed among adolescents. The Covaxin vaccine is relatively safe for adolescents, but continuous vigilance should be maintained in the future to monitor any adverse events following immunization (AEFI). In the present study, AEFI was not associated with age, gender, education, locality, comorbidity, COVID-19 infection, and allergies among adolescents.

Key words: COVID 19 Vaccine; Adverse Events Following Immunization; Adolescent; Co-morbidity


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Anju Damu Ade
Articles by Visweswara Rao Guthi
Articles by Chandrasekhar Vallepalli
Articles by Prathyusha T V D
Articles by Nagaraj Kondagunta
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Ade AD, Guthi VR, Vallepalli C, D PTV, Kondagunta N. Adverse events with COVID-19 vaccination among adolescents (15–18 years age group) in South India. Natl J Physiol Pharm Pharmacol. 2023; 13(11): 2201-2206. doi:10.5455/njppp.2023.13.03142202310042023


Web Style

Ade AD, Guthi VR, Vallepalli C, D PTV, Kondagunta N. Adverse events with COVID-19 vaccination among adolescents (15–18 years age group) in South India. https://www.njppp.com/?mno=146948 [Access: February 02, 2024]. doi:10.5455/njppp.2023.13.03142202310042023


AMA (American Medical Association) Style

Ade AD, Guthi VR, Vallepalli C, D PTV, Kondagunta N. Adverse events with COVID-19 vaccination among adolescents (15–18 years age group) in South India. Natl J Physiol Pharm Pharmacol. 2023; 13(11): 2201-2206. doi:10.5455/njppp.2023.13.03142202310042023



Vancouver/ICMJE Style

Ade AD, Guthi VR, Vallepalli C, D PTV, Kondagunta N. Adverse events with COVID-19 vaccination among adolescents (15–18 years age group) in South India. Natl J Physiol Pharm Pharmacol. (2023), [cited February 02, 2024]; 13(11): 2201-2206. doi:10.5455/njppp.2023.13.03142202310042023



Harvard Style

Ade, A. D., Guthi, . V. R., Vallepalli, . C., D, . P. T. V. & Kondagunta, . N. (2023) Adverse events with COVID-19 vaccination among adolescents (15–18 years age group) in South India. Natl J Physiol Pharm Pharmacol, 13 (11), 2201-2206. doi:10.5455/njppp.2023.13.03142202310042023



Turabian Style

Ade, Anju Damu, Visweswara Rao Guthi, Chandrasekhar Vallepalli, Prathyusha T V D, and Nagaraj Kondagunta. 2023. Adverse events with COVID-19 vaccination among adolescents (15–18 years age group) in South India. National Journal of Physiology, Pharmacy and Pharmacology, 13 (11), 2201-2206. doi:10.5455/njppp.2023.13.03142202310042023



Chicago Style

Ade, Anju Damu, Visweswara Rao Guthi, Chandrasekhar Vallepalli, Prathyusha T V D, and Nagaraj Kondagunta. "Adverse events with COVID-19 vaccination among adolescents (15–18 years age group) in South India." National Journal of Physiology, Pharmacy and Pharmacology 13 (2023), 2201-2206. doi:10.5455/njppp.2023.13.03142202310042023



MLA (The Modern Language Association) Style

Ade, Anju Damu, Visweswara Rao Guthi, Chandrasekhar Vallepalli, Prathyusha T V D, and Nagaraj Kondagunta. "Adverse events with COVID-19 vaccination among adolescents (15–18 years age group) in South India." National Journal of Physiology, Pharmacy and Pharmacology 13.11 (2023), 2201-2206. Print. doi:10.5455/njppp.2023.13.03142202310042023



APA (American Psychological Association) Style

Ade, A. D., Guthi, . V. R., Vallepalli, . C., D, . P. T. V. & Kondagunta, . N. (2023) Adverse events with COVID-19 vaccination among adolescents (15–18 years age group) in South India. National Journal of Physiology, Pharmacy and Pharmacology, 13 (11), 2201-2206. doi:10.5455/njppp.2023.13.03142202310042023